1. Home
  2. TOP vs GANX Comparison

TOP vs GANX Comparison

Compare TOP & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOP
  • GANX
  • Stock Information
  • Founded
  • TOP 2015
  • GANX 2017
  • Country
  • TOP Hong Kong
  • GANX United States
  • Employees
  • TOP N/A
  • GANX N/A
  • Industry
  • TOP Investment Bankers/Brokers/Service
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOP Finance
  • GANX Health Care
  • Exchange
  • TOP Nasdaq
  • GANX Nasdaq
  • Market Cap
  • TOP 46.0M
  • GANX 51.8M
  • IPO Year
  • TOP 2022
  • GANX 2021
  • Fundamental
  • Price
  • TOP $1.23
  • GANX $1.69
  • Analyst Decision
  • TOP
  • GANX Strong Buy
  • Analyst Count
  • TOP 0
  • GANX 5
  • Target Price
  • TOP N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • TOP 49.1K
  • GANX 304.5K
  • Earning Date
  • TOP 08-05-2025
  • GANX 08-07-2025
  • Dividend Yield
  • TOP N/A
  • GANX N/A
  • EPS Growth
  • TOP N/A
  • GANX N/A
  • EPS
  • TOP N/A
  • GANX N/A
  • Revenue
  • TOP $2,730,890.00
  • GANX N/A
  • Revenue This Year
  • TOP N/A
  • GANX N/A
  • Revenue Next Year
  • TOP N/A
  • GANX N/A
  • P/E Ratio
  • TOP N/A
  • GANX N/A
  • Revenue Growth
  • TOP N/A
  • GANX N/A
  • 52 Week Low
  • TOP $1.00
  • GANX $0.89
  • 52 Week High
  • TOP $1.94
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • TOP 46.96
  • GANX 48.21
  • Support Level
  • TOP $1.18
  • GANX $1.55
  • Resistance Level
  • TOP $1.25
  • GANX $1.72
  • Average True Range (ATR)
  • TOP 0.05
  • GANX 0.13
  • MACD
  • TOP -0.00
  • GANX 0.00
  • Stochastic Oscillator
  • TOP 37.82
  • GANX 40.24

About TOP TOP Financial Group Limited

TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: